Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CLOVER HEALTH INVESTMENTS, CORP. /DECLOV · Entity 4419 | Director | January 06, 2026 | January 08, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CLOVER HEALTH INVESTMENTS, CORP. /DE
Report date January 06, 2026 · Filed January 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 605,980 |
Reported balance
After 2026-01-06 transaction · row 1
1 source rowRow 1 · 2026-01-06 · Grant · Acquired 79,365 · Balance 605,980 F1: Represents shares of Class A Common Stock underlying an award of time-based restricted stock units (RSUs). The RSUs will vest in full on the first anniversary of January 6, 2026, subject to the Reporting Person's continued service as a director through such vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares of Class A Common Stock underlying an award of time-based restricted stock units (RSUs). The RSUs will vest in full on the first anniversary of January 6, 2026, subject to the Reporting Person's continued service as a director through such vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 06, 2026 Filed Jan 8, 2026 21:20 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | GrantClass A Common Stock | 79,365 | $0.00 | $0.00 |
DisclosureSEC source: 0001801170-26-000010 · wk-form4_1767907231.xml · nonDerivative · entry 1 Kouzoukas Demetrios L. · CIK 0001856511 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 605,980 F1 · shares: Represents shares of Class A Common Stock underlying an award of time-based restricted stock units (RSUs). The RSUs will vest in full on the first anniversary of January 6, 2026, subject to the Reporting Person's continued service as a director through such vesting date. Read SEC document |
| January 06, 2025 Filed Jan 8, 2025 21:28 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | GrantClass A Common Stock | 60,975 | $0.00 | $0.00 |
DisclosureSEC source: 0001801170-25-000012 · wk-form4_1736371725.xml · nonDerivative · entry 1 Kouzoukas Demetrios L. · CIK 0001856511 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 526,615 F1 · shares: Represents shares of Class A Common Stock underlying an award of time-based restricted stock units (RSUs). The RSUs will vest in full on the first anniversary of January 6, 2025, subject to the Reporting Person's continued service as a director through such vesting date. Read SEC document |
| January 03, 2024 Filed Jan 5, 2024 21:16 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | GrantClass A Common Stock | 206,185 | $0.97 | $199,999.45 |
DisclosureSEC source: 0001801170-24-000024 · wk-form4_1704489375.xml · nonDerivative · entry 1 Kouzoukas Demetrios L. · CIK 0001856511 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 465,640 F1 · shares: Represents shares of Class A Common Stock underlying an award of time-based restricted stock units (RSUs). The RSUs will vest in full on the first anniversary of January 3, 2024, subject to the Reporting Person's continued service as a director through such vesting date. Read SEC document |
| May 15, 2023 Filed May 17, 2023 01:39 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | GrantClass A Common Stock | 36,585 | $0.00 | $0.00 |
DisclosureSEC source: 0000895345-23-000304 · form4.xml · nonDerivative · entry 1 Kouzoukas Demetrios L. · CIK 0001856511 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 259,455 F1 · shares: Represents shares of Class A common stock of Clover Health Investments, Corp. (the "Company") underlying a time-based restricted stock unit award ("RSUs"). The RSUs will vest in full on the first anniversary of May 15, 2023, subject to the Reporting Person's continued service as a member of the Company's Board of Directors through such vesting date. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 21:33 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | GrantClass A Common Stock | 176,991 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-000467 · wf-form4_167295440741586.xml · nonDerivative · entry 1 Kouzoukas Demetrios L. · CIK 0001856511 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 222,870 F1 · shares: Represents shares of Class A common stock of Clover Health Investments, Corp. (the "Company") underlying a time-based restricted stock unit award ("RSUs"). The RSUs will vest in full on the first anniversary of January 3, 2023, subject to the Reporting Person's continued service as a member of the Company's Board of Directors through such vesting date. Read SEC document |
| September 22, 2022 Filed Sep 26, 2022 22:01 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Exercise / conversionRestricted Stock Unit · Derivative | Not disclosed | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-22-025506 · wf-form4_166422966400809.xml · derivative · entry 3 Kouzoukas Demetrios L. · CIK 0001856511 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 25,608 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement for no consideration. F3 · derivative.exercise_date: One hundred percent of the shares subject to the RSU award vested on the date of the 2022 Annual Meeting. F3 · derivative.expiration_date: One hundred percent of the shares subject to the RSU award vested on the date of the 2022 Annual Meeting. Read SEC document |
| September 22, 2022 Filed Sep 26, 2022 22:01 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | GrantClass A Common Stock | 20,271 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-22-025506 · wf-form4_166422966400809.xml · nonDerivative · entry 2 Kouzoukas Demetrios L. · CIK 0001856511 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,879 F2 · shares: Represents shares of Class A common stock underlying a time-based RSU. One hundred percent of the RSUs will vest on the first anniversary of the Date of Grant, subject to the Reporting Person's continued service as a member of the Company's Board of Directors through such date. Read SEC document |
| September 22, 2022 Filed Sep 26, 2022 22:01 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Exercise / conversionClass A Common Stock | 25,608 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-22-025506 · wf-form4_166422966400809.xml · nonDerivative · entry 1 Kouzoukas Demetrios L. · CIK 0001856511 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,608 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement for no consideration. Read SEC document |
| April 13, 2021 Filed Apr 15, 2021 20:18 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | GrantRestricted Stock Unit · Derivative | 25,608 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-026829 · doc4.xml · derivative · entry 1 Kouzoukas Demetrios L. · CIK 0001856511 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,608 Underlying: Class A Common Stock · 25,608 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement for no consideration. F2 · derivative.exercise_date: 100% of the shares subject to the award shall vest on the date of the 2022 Annual Meeting, subject to Mr. Kouzoukas' continued service as a member of the Board through such vesting date. F2 · derivative.expiration_date: 100% of the shares subject to the award shall vest on the date of the 2022 Annual Meeting, subject to Mr. Kouzoukas' continued service as a member of the Board through such vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.